[Intravenous feeding--possibilities and limits in the use of glucose and xylitol following trauma and infection, with special reference to liver metabolism].
Numerous side-effects of intravenously administered substrates have taught us that we have to reevaluate the dosages of the various substitutes of an intravenous regimen after trauma and during sepsis, whereby the limitation of glucose calories to approx. 3 g/kg B.W./day is of great metabolic importance. Additionally required calories can be provided either in the form of a lipid emulsion in a dosage of 1 to maximally 1.5 g/kg B.W./day and/or additionally xylitol in a dosage of max. 3 g/kg B.W./day.
D001424:Bacterial Infections / Q000097:blood / Q000628:therapy*; D001786:Blood Glucose / Q000378:metabolism; D004734:Energy Metabolism; D005947:Glucose / Q000008:administration & dosage*; D005950:Glucose Solution, Hypertonic / Q000008:administration & dosage*; D006801:Humans; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood; D008099:Liver / Q000378:metabolism*; D010289:Parenteral Nutrition, Total; D014947:Wounds and Injuries / Q000097:blood / Q000628:therapy*; D014993:Xylitol / Q000008:administration & dosage* / Q000097:blood
D001786:Blood Glucose; D005950:Glucose Solution, Hypertonic; D007328:Insulin; D008055:Lipids; D005947:Glucose; D014993:Xylitol
Intravenöse Ernährung--Möglichkeiten und Grenzen der Anwendung von Glukose und Xylit nach Trauma und Sepsis unter besonderer Berücksichtigung des Leberstoffwechsels.